Cencora to acquire an additional stake in OneOncology from TPG Capital at a $7.4bn valuation.

Cencora, an American drug wholesale and distribution company, agreed to acquire an additional stake in OneOncology, a physician-led national platform empowering independent medical specialty practices rooted in oncology, from TPG Capital, a global alternative asset management firm, at a $7.4bn valuation. "We are excited to accelerate our acquisition of OneOncology, which will advance our management services organization and aligns with our approach of making growth-oriented investments that support our pharmaceutical-centric strategy," Bob Mauch, Cencora President and CEO.